Quintara Bio

Quintara Bio is a private, revenue-generating life sciences services company headquartered in Cambridge, Massachusetts, with additional operational sites across the US. The company offers a comprehensive suite of genomics and molecular biology services, positioning itself as a fast, cost-effective partner for research and development. Its business model is built on providing outsourced technical expertise, from basic Sanger sequencing to advanced single-cell and long-read sequencing, alongside gene and antibody services. Quintara leverages promotional pricing and a multi-site presence to capture market share in the competitive contract research services sector.

Integrated service platform providing access to Sanger, NGS (Illumina), long-read (Nanopore, PacBio) sequencing, gene synthesis, molecular cloning, plasmid prep, antibody/protein services, and IVT mRNA synthesis.

Quintara operates in the highly competitive contract research services market, competing against large global CROs/service providers (e.g., Eurofins, Azenta) and numerous small, specialized labs. It differentiates through aggressive promotional pricing, a broad service menu, and a multi-location presence targeting key US biotech hubs directly.